Onderneming Freeline Therapeutics Holdings plc
Aandelen
FRLN
US35655L2060
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 152
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Markus Hörer
FOU | Founder | - | 01-01-15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15-03-21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16-05-22 |
Chief Tech/Sci/R&D Officer | 57 | 01-03-22 | |
Pamela Foulds
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-11-21 |
James Bircher
COO | Chief Operating Officer | 56 | 01-07-21 |
Naomi Aoki
IRC | Investor Relations Contact | - | - |
Chip McCorkle
LAW | General Counsel | - | - |
Nicole Jones
HRO | Human Resources Officer | 54 | 11-07-22 |
Amy J. Spandau
PRN | Corporate Officer/Principal | - | 01-02-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chris Hollowood
CHM | Chairman | 50 | 01-12-15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15-03-21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 65 369 417 | 64 715 513 ( 99,00 %) | 0 | 99,00 % |
Bedrijfsgegevens
Freeline Therapeutics Holdings Plc
Sycamore House Gunnels Wood Road
SG1 2BP, Stevenage
+44 14 3890 6870
http://www.freeline.lifeSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,26% | 104 mld. | |
+1,41% | 97,42 mld. | |
+0,79% | 22,2 mld. | |
-17,84% | 21,23 mld. | |
-11,11% | 18,33 mld. | |
-42,83% | 16,35 mld. | |
-17,63% | 15,06 mld. | |
+4,55% | 13,98 mld. | |
+32,11% | 11,66 mld. |